Market Overview:
The global bone growth stimulant market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market is segmented by type, application and region. By type, the external bone growth stimulant segment is expected to dominate the market in 2018 and is projected to grow at a CAGR of 5.8%. The implanted bone growth stimulator segment is projected to grow at a CAGR of 4.9%. By application, the spinal fusion surgery segment dominates the global market with a share of more than 50% in 2018 and it is projected to grow at a CAGR of 5%. The delayed union and nonunion fracture surgery applications are also growing rapidly owing to increasing incidence rates for these surgeries globally.
Product Definition:
Bone growth stimulants are medications or natural substances that promote bone growth. They are used to treat conditions such as osteoporosis, bone fractures, and delayed union of bones. Bone growth stimulants can also be used to increase the height of children with short stature.
External Bone Growth Stimulant:
External Bone Growth Stimulant is a drug that increases bone growth by stimulating cells in the body to grow and multiply. It is used for treating conditions such as osteoporosis, anemia, and arthritis. Osteoporosis causes the bones of the patient to become weak and brittle which can result in severe fractures if not treated.
Implanted Bone Growth Stimulant:
An implanted bone growth stimulant is a drug that increases the rate of bone growth. It is used in the treatment of osteoporosis and arthritis. The most common type of implantable bone growth stimulator includes an electric pulse generator, which sends an electrical signal to the spine; this causes bones to grow at a faster rate.
Application Insights:
The spinal fusion surgery segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to an increase in number of spinal fusion surgeries being performed worldwide. According to a study published by NCBI, it is estimated that around 250,000-500,000 people suffer from fractures annually and around 10 million fractures occur every year globally. As per this same source, about 75% of these injuries are caused by falls which results in low-back pain each year. Thus resulting in high demand for bone growth stimulants post spinal fusion surgeries across the globe.
The others application segment includes dental procedures involving bone grafts or implants as well as nonunion.
Regional Analysis:
North America dominated the global bone growth stimulant market in 2017. The presence of well-established healthcare facilities and highly developed healthcare infrastructure are some factors responsible for its large share. Moreover, the availability of a wide range of technologically advanced products is anticipated to drive the regional market further.
The Asia Pacific region is expected to witness lucrative growth over the forecast period owing to rising medical tourism and increasing incidence of road accidents in developing countries such as India, China, and Malaysia among others. In addition, rapidly growing dental care industry coupled with improving healthcare infrastructure will boost demand for these products in this region over the forecast period.
Growth Factors:
- Increasing incidence of bone fractures and osteoporosis
- Growing geriatric population
- Rising awareness about the benefits of bone growth stimulants
- Technological advancements in the field of bone growth stimulants
- Availability of affordable and effective products
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone Growth Stimulant Market Research Report
By Type
External Bone Growth Stimulant, Implanted Bone Growth Stimulant, Ultrasound Bone Growth Stimulant, Bone Morphogenetic Protein, Platelet Rich Plasma, Other
By Application
Spinal Fusion Surgery, Delayed Union And Nonunion Fracture, Oral And Maxillofacial Surgery, Others
By Companies
Bioventus LLC, DJO Finance LLC, Medtronic plc, Orthofix International NV, Zimmer Biomet Holdings, Stryker Corporation, Isto Biologics, Harvest Technologies Corporation, DePuy Synthes, Arthrex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Bone Growth Stimulant Market Report Segments:
The global Bone Growth Stimulant market is segmented on the basis of:
Types
External Bone Growth Stimulant, Implanted Bone Growth Stimulant, Ultrasound Bone Growth Stimulant, Bone Morphogenetic Protein, Platelet Rich Plasma, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Fusion Surgery, Delayed Union And Nonunion Fracture, Oral And Maxillofacial Surgery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bioventus LLC
- DJO Finance LLC
- Medtronic plc
- Orthofix International NV
- Zimmer Biomet Holdings
- Stryker Corporation
- Isto Biologics
- Harvest Technologies Corporation
- DePuy Synthes
- Arthrex
Highlights of The Bone Growth Stimulant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Bone Growth Stimulant
- Implanted Bone Growth Stimulant
- Ultrasound Bone Growth Stimulant
- Bone Morphogenetic Protein
- Platelet Rich Plasma
- Other
- By Application:
- Spinal Fusion Surgery
- Delayed Union And Nonunion Fracture
- Oral And Maxillofacial Surgery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone Growth Stimulant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone growth stimulant is a medication that stimulates the growth of bones. It is used to treat conditions such as osteoporosis or bone fractures.
Some of the major companies in the bone growth stimulant market are Bioventus LLC, DJO Finance LLC, Medtronic plc, Orthofix International NV, Zimmer Biomet Holdings, Stryker Corporation, Isto Biologics, Harvest Technologies Corporation, DePuy Synthes, Arthrex.
The bone growth stimulant market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bone Growth Stimulant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bone Growth Stimulant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bone Growth Stimulant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bone Growth Stimulant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bone Growth Stimulant Market Size & Forecast, 2020-2028
4.5.1 Bone Growth Stimulant Market Size and Y-o-Y Growth
4.5.2 Bone Growth Stimulant Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 External Bone Growth Stimulant
5.2.2 Implanted Bone Growth Stimulant
5.2.3 Ultrasound Bone Growth Stimulant
5.2.4 Bone Morphogenetic Protein
5.2.5 Platelet Rich Plasma
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Spinal Fusion Surgery
6.2.2 Delayed Union And Nonunion Fracture
6.2.3 Oral And Maxillofacial Surgery
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bone Growth Stimulant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bone Growth Stimulant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 External Bone Growth Stimulant
9.6.2 Implanted Bone Growth Stimulant
9.6.3 Ultrasound Bone Growth Stimulant
9.6.4 Bone Morphogenetic Protein
9.6.5 Platelet Rich Plasma
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Spinal Fusion Surgery
9.10.2 Delayed Union And Nonunion Fracture
9.10.3 Oral And Maxillofacial Surgery
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 External Bone Growth Stimulant
10.6.2 Implanted Bone Growth Stimulant
10.6.3 Ultrasound Bone Growth Stimulant
10.6.4 Bone Morphogenetic Protein
10.6.5 Platelet Rich Plasma
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Spinal Fusion Surgery
10.10.2 Delayed Union And Nonunion Fracture
10.10.3 Oral And Maxillofacial Surgery
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 External Bone Growth Stimulant
11.6.2 Implanted Bone Growth Stimulant
11.6.3 Ultrasound Bone Growth Stimulant
11.6.4 Bone Morphogenetic Protein
11.6.5 Platelet Rich Plasma
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Spinal Fusion Surgery
11.10.2 Delayed Union And Nonunion Fracture
11.10.3 Oral And Maxillofacial Surgery
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 External Bone Growth Stimulant
12.6.2 Implanted Bone Growth Stimulant
12.6.3 Ultrasound Bone Growth Stimulant
12.6.4 Bone Morphogenetic Protein
12.6.5 Platelet Rich Plasma
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Spinal Fusion Surgery
12.10.2 Delayed Union And Nonunion Fracture
12.10.3 Oral And Maxillofacial Surgery
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 External Bone Growth Stimulant
13.6.2 Implanted Bone Growth Stimulant
13.6.3 Ultrasound Bone Growth Stimulant
13.6.4 Bone Morphogenetic Protein
13.6.5 Platelet Rich Plasma
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Spinal Fusion Surgery
13.10.2 Delayed Union And Nonunion Fracture
13.10.3 Oral And Maxillofacial Surgery
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bone Growth Stimulant Market: Competitive Dashboard
14.2 Global Bone Growth Stimulant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bioventus LLC
14.3.2 DJO Finance LLC
14.3.3 Medtronic plc
14.3.4 Orthofix International NV
14.3.5 Zimmer Biomet Holdings
14.3.6 Stryker Corporation
14.3.7 Isto Biologics
14.3.8 Harvest Technologies Corporation
14.3.9 DePuy Synthes
14.3.10 Arthrex
